ERBB2 and breast cancer: For example, HNF4A expression can be used as a potential diagnostic tool to discriminate primary gastric cancer from breast cancer metastasis in a Brazilian cohort [46], the ERBB2 gene can be used as a diagnostic marker of early systemic cancer [47], and VCAN is a potential prognostic biomarker for gastric cancer [48].